Get the Stockscreener App
0.8968
1.72%
-0.0157
Enlivex Therapeutics Ltd stock is traded at $0.8968, with a volume of 220.13K.
It is down -1.72% in the last 24 hours and down -18.10% over the past month.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
See More
Previous Close:
$0.9125
Open:
$0.9098
24h Volume:
220.13K
Relative Volume:
1.10
Market Cap:
$21.79M
Revenue:
-
Net Income/Loss:
$-14.33M
P/E Ratio:
-1.3588
EPS:
-0.66
Net Cash Flow:
$-13.21M
1W Performance:
-9.53%
1M Performance:
-18.10%
6M Performance:
-8.44%
1Y Performance:
+6.63%
1-Day Range:
$0.8313
$0.9408
1-Week Range:
$0.8313
$1.00
52-Week Range:
$0.828
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Name
Enlivex Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare ENLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
0.8968 | 22.17M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-02-21 | Reiterated | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Stock (ENLV) Latest News
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Utica Observer Dispatch
Detecting price anomalies in Enlivex Therapeutics Ltd. with AIWeekly Gains Report & Growth Focused Entry Point Reports - newser.com
Is Enlivex Therapeutics Ltd. stock cheap at current valuationEarnings Recap Report & Capital Efficient Trade Techniques - newser.com
why enlivex therapeutics ltd. stock is considered a top pickQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Short interest data insights for Enlivex Therapeutics Ltd.Trade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Is Enlivex Therapeutics Ltd. stock supported by strong cash flowsJuly 2025 Analyst Calls & Fast Entry High Yield Tips - newser.com
Using portfolio simulators with Enlivex Therapeutics Ltd. includedEarnings Overview Report & Safe Entry Momentum Stock Tips - newser.com
Price action breakdown for Enlivex Therapeutics Ltd.July 2025 PostEarnings & Weekly High Return Opportunities - newser.com
What analysts say about Enlivex Therapeutics Ltd stockBullish Engulfing Patterns & Free High Impact Stock Picks - earlytimes.in
Published on: 2025-11-16 17:25:18 - newser.com
How Enlivex Therapeutics Ltd. stock reacts to job market data2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com
Enlivex Reports Q3 2025 Financial Results Amidst Operational Challenges - MSN
Comparing Enlivex Therapeutics Ltd. in custom built stock radarsWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
Analyzing recovery setups for Enlivex Therapeutics Ltd. investorsJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
Can Enlivex Therapeutics Ltd. stock deliver strong Q4 earningsTrade Entry Report & Weekly Watchlist for Consistent Profits - Fundação Cultural do Pará
Why analysts remain bullish on Enlivex Therapeutics Ltd. stockEntry Point & AI Powered Market Entry Ideas - newser.com
Enlivex Therapeutics Ltd Stock Analysis and ForecastRelative Strength Index (RSI) & Register for the Next Free Workshop - earlytimes.in
Backtesting results for Enlivex Therapeutics Ltd. trading strategies2025 Investor Takeaways & Community Consensus Trade Signals - newser.com
Why Enlivex Therapeutics Ltd. stock is considered a top pickTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - newser.com
What’s the recovery path for long term holders of Enlivex Therapeutics Ltd.Weekly Stock Summary & Verified Momentum Stock Alerts - newser.com
Will Enlivex Therapeutics Ltd. stock maintain dividend yieldJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
Enlivex Reschedules Annual Meeting Due to Lack of Quorum - TipRanks
Can Enlivex Therapeutics Ltd. stock maintain operating marginsJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
Enlivex Therapeutics Ltd Stock (ENLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):